DocResponse Overview

  • Founded
  • 2015
  • Status
  • Private
  • Employees
  • 13
  • Latest Deal Type
  • Series 2
  • Latest Deal Amount
  • $700K
Latest Deal Amount
  • Investors
  • 2

DocResponse General Information


Developer of a medical office digital check-in, practice workflow, and documentation solution. The company develops an application which allows healthcare diagnostics for supporting the clinical decision.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Services
Other Industries
Application Software
Primary Office
  • 21175 Tomball Parkway
  • Suite 487
  • Houston, TX 77070-1655
  • United States
+1 (832) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

DocResponse Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 28-Feb-2019 $700K 00.00 Completed Generating Revenue
2. Seed Round 31-Oct-2016 00000 00000 00.00 Completed Generating Revenue
1. Accelerator/Incubator 26-Jan-2016 Completed Startup
To view DocResponse’s complete valuation and funding history, request access »

DocResponse Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 0,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
To view DocResponse’s complete cap table history, request access »

DocResponse Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Developer of a medical office digital check-in, practice workflow, and documentation solution. The company develops an a
Other Healthcare Services
Houston, TX
13 As of 2021
000000000 00.00


dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut ali
000000000000000000 00000000
Stockholm, Sweden
000 As of 0000
0000000000 0 00000


psum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolo
0000000000000 00000000
Barcelona, Spain
00 As of 0000
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

DocResponse Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Kry Venture Capital-Backed Stockholm, Sweden 000 00000 0000000000 0 00000
00000000 Venture Capital-Backed Barcelona, Spain 00 000.00 0000000000 0 000.00
00000000 Formerly VC-backed Raleigh, NC 000 00000 000000000 - 00000
00000 000000 Venture Capital-Backed Hoboken, NJ 00 000.00 000000000000 000.00
To view DocResponse’s complete competitors history, request access »

DocResponse Executive Team (5)

Name Title Board Seat Contact Info
Tarek Fahl MD Founder, Chief Executive Officer & Board Member
Nadia Fahl Chief Financial Officer
Jinan Duncan Chief Operating Officer
Carlos Maynard Chief Technology Officer & IT Director
You’re viewing 4 of 5 executive team members. Get the full list »

DocResponse Board Members (1)

Name Representing Role Since
Tarek Fahl MD DocResponse Founder, Chief Executive Officer & Board Member 000 0000
To view DocResponse’s complete board members history, request access »

DocResponse Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DocResponse Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Hartford Lab Corporation Minority 000 0000 000000 0
TMC Innovation Accelerator/Incubator 000 0000 000000 0
To view DocResponse’s complete investors history, request access »